Cancer pain
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Cancer patients to whom oral formulation of strong opioid analgesic was newly prescribed
Exclusion criteria
Exclusion criteria: *Patients who received radiotherapy or chemotherapy during 10 days before start of ingestion of opioid analgesics or during study period *Patients who received surgical operation during 7 days before start of ingestion of opioid analgesics or during study period *Patients who took antiemetics or laxatives due to other reasons than prevention of opioid-induced gastrointestinal dysfunction *Patients who had diarrhea or constipation before ingestion of opioid analgesics *Patients who had nausea or vomiting due to organic dysfunction including brain tumor *Patients whose performance status was 3 or 4
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of opioid-induced constipation, nausea and vomiting | — |
Secondary
| Measure | Time frame |
|---|---|
| Prevalence of premedication, Choice of laxatives and antiemetics | — |
Countries
Japan
Contacts
Gifu University Hospital Pharmacy